[Biological therapy in sympathetic ophthalmia refractory to combined immunosuppressive treatment]

Arch Soc Esp Oftalmol. 2011 Jul;86(7):222-3. doi: 10.1016/j.oftal.2011.02.009. Epub 2011 May 20.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab
  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Biological Therapy*
  • Combined Modality Therapy
  • Cyclosporine / administration & dosage
  • Cyclosporine / therapeutic use
  • Drug Resistance
  • Drug Therapy, Combination
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use*
  • Methotrexate / administration & dosage
  • Methotrexate / therapeutic use
  • Ophthalmia, Sympathetic / drug therapy
  • Ophthalmia, Sympathetic / etiology
  • Ophthalmia, Sympathetic / therapy*
  • Postoperative Complications / drug therapy
  • Postoperative Complications / etiology
  • Postoperative Complications / therapy*
  • Prednisone / therapeutic use
  • Retinal Detachment / surgery
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Cyclosporine
  • Adalimumab
  • Prednisone
  • Methotrexate